MANE
Veradermics, IncCompany Information
- Company Name
- Veradermics, Inc
- CIK
- CIK0001827635
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- MANE: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- MANE
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-02-06
- Last sale
- 2026-08-19
- Shares purchased (TTM)
- 2,592,284
- Shares sold (TTM)
- 961,000
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 34,030,543
- Shares outstanding
- 40,436,264
- Ownership
- 84.16%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- -9.58%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||
| Cash And Cash Equivalents At Carrying Value | 319 | 168 | 22 | ||||||
| Available For Sale Securities Debt Securities Current | 501 | 222 | 120 | ||||||
| Prepaid Expense And Other Assets Current | 5 | 6 | 11 | ||||||
| Assets Current | 825 | 397 | 152 | ||||||
Assets Noncurrent | |||||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 0 | 0 | ||||||
| Assets Noncurrent | 1 | 0 | 0 | ||||||
| Assets | 826 | 397 | 153 | ||||||
Liabilities Current | |||||||||
| Accounts Payable Current | 6 | 1 | 2 | ||||||
| Accrued Liabilities Current | 5 | 6 | 7 | ||||||
| Other Liabilities Current | 0 | 0 | 0 | ||||||
| Liabilities Current | 12 | 7 | 9 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | ||||||
| Liabilities | 12 | 7 | 9 | ||||||
Temporary Equity | |||||||||
| Temporary Equity Shares Subscribed But Unissued Subscriptions Receivable | 0 | 0 | -2 | ||||||
Stockholders Equity | |||||||||
| Preferred Stock Value | 0 | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 989 | 543 | 2 | ||||||
| Stockholders Equity Note Subscriptions Receivable | -1 | -1 | - | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1 | -1 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -174 | -151 | -123 | ||||||
| Stockholders Equity | 814 | 391 | -121 | ||||||
| Liabilities And Stockholders Equity | 826 | 397 | 153 | ||||||
| Series A Preferred Stock | 0 | 0 | 0 | ||||||
| Series B Preferred Stock | 0 | 0 | 0 | ||||||
| Series C Preferred Stock | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 25 | 25 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 267 | ||||||
| Common Stock Shares Issued | 42 | 37 | 1 | ||||||
| Shares Outstanding | 42 | 37 | 1 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVeradermics, Inc (MANE) — SEC Financial Statements & Analysis
Veradermics, Inc (MANE) is a pharmaceutical preparations company, incorporated in DE. Veradermics, Inc trades on NYSE as: MANE. Veradermics, Inc (MANE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, Veradermics, Inc carries a market cap of $4.97B, a P/B ratio of 6.11x, and an enterprise value of $4.65B. On the balance sheet, it maintains a current ratio of 70.53x, a quick ratio of 70.11x, working capital of $813.05M, a debt-to-equity ratio of 0.01x, a debt ratio of 0.01, and net debt of $-319.33M. Figures sourced from SEC EDGAR.
- Market Cap
- $4.97B
- P/B TTM
- 6.11x
- Debt To Equity
- 0.01x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Veradermics, Inc in?
Veradermics, Inc (MANE) operates in the Pharmaceutical Preparations industry.
What exchange does MANE trade on?
Veradermics, Inc (MANE) trades on the NYSE.
Where is Veradermics, Inc incorporated?
Veradermics, Inc is incorporated in DE.
When was Veradermics, Inc (MANE)'s most recent SEC filing?
Veradermics, Inc (MANE)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is MANE's market cap?
Veradermics, Inc (MANE) has a market capitalization of $4.97B as of 2026-06-30.